Outpatient Use of Low Molecular Weight Heparin Monotherapy for First-Line Treatment of Venous Thromboembolism in Advanced Cancer

BACKGROUND. Evidence-based treatment guidelines recommend low molecular weight heparin (LMWH) monotherapy for cancer-associated venous thromboembolism (VTE). This analysis assessed the first-line treatment strategies for VTE in patients with advanced solid tumors. METHODS. Using administrative data...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Delate, Thomas, Witt, Daniel M., Ritzwoller, Debra, Weeks, Jane C., Kushi, Lawrence, Hornbrook, Mark C., Aiello Bowles, Erin J., Schrag, Deborah
Format: Artigo
Jezik:Inglês
Izdano: AlphaMed Press 2012
Teme:
Symptom Management and Supportive Care
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3316928/
https://ncbi.nlm.nih.gov/pubmed/22334451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0323
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items